LIDOCAINE HCI AND EPINEPHRINE is a Infiltration; Perineural Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Lidocaine Hydrochloride Anhydrous; Epinephrine Bitartrate.
| Product ID | 51662-1505_a0997348-6275-060a-e053-2a95a90abea7 |
| NDC | 51662-1505 |
| Product Type | Human Prescription Drug |
| Proprietary Name | LIDOCAINE HCI AND EPINEPHRINE |
| Generic Name | Lidocaine Hci And Epinephrine |
| Dosage Form | Injection, Solution |
| Route of Administration | INFILTRATION; PERINEURAL |
| Marketing Start Date | 2020-03-11 |
| Marketing Category | NDA / NDA |
| Application Number | NDA006488 |
| Labeler Name | HF Acquisition Co LLC, DBA HealthFirst |
| Substance Name | LIDOCAINE HYDROCHLORIDE ANHYDROUS; EPINEPHRINE BITARTRATE |
| Active Ingredient Strength | 20 mg/mL; mg/mL |
| Pharm Classes | Amide Local Anesthetic [EPC],Amides [CS],Antiarrhythmic [EPC],Local Anesthesia [PE],Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |